Vance Thompson Vision ND

NCT05136924

Phase 2, Status unknown, 2021, 20 people, 30 Nov 2021, clinicaltrials.gov

NCT05082974

Phase 3, Completed, 2021, 40 people, 19 Oct 2021, clinicaltrials.gov